These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 2627990)
1. Phenotypic and functional characterization of normal and malignant terminal B (plasma) cells. Anderson KC; Cochran M; Barut BA Eur J Haematol Suppl; 1989; 51():19-26. PubMed ID: 2627990 [TBL] [Abstract][Full Text] [Related]
2. Antigens on human plasma cells identified by monoclonal antibodies. Anderson KC; Park EK; Bates MP; Leonard RC; Hardy R; Schlossman SF; Nadler LM J Immunol; 1983 Mar; 130(3):1132-8. PubMed ID: 6401780 [TBL] [Abstract][Full Text] [Related]
3. Sequential maturation stages of monoclonal B lineage cells from blood, spleen, lymph node, and bone marrow from a terminal myeloma patient. Jensen GS; Mant MJ; Pilarski LM Am J Hematol; 1992 Nov; 41(3):199-208. PubMed ID: 1384318 [TBL] [Abstract][Full Text] [Related]
4. Expression of multiple beta 1 integrins on circulating monoclonal B cells in patients with multiple myeloma. Jensen GS; Belch AR; Mant MJ; Ruether BA; Yacyshyn BR; Pilarski LM Am J Hematol; 1993 May; 43(1):29-36. PubMed ID: 7686332 [TBL] [Abstract][Full Text] [Related]
5. A monoclonal antibody with reactivity restricted to normal and neoplastic plasma cells. Anderson KC; Bates MP; Slaughenhoupt B; Schlossman SF; Nadler LM J Immunol; 1984 Jun; 132(6):3172-9. PubMed ID: 6427334 [TBL] [Abstract][Full Text] [Related]
6. Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma. Caligaris-Cappio F; Bergui L; Tesio L; Pizzolo G; Malavasi F; Chilosi M; Campana D; van Camp B; Janossy G J Clin Invest; 1985 Sep; 76(3):1243-51. PubMed ID: 2931452 [TBL] [Abstract][Full Text] [Related]
7. Analysis of the B-cell compartment in plasma cell leukemia and multiple myeloma: immunoglobulin gene rearrangement of EBV-infected B-cell lines. Commes T; Clofent G; Ghanem N; Zhang XG; Lefranc MP; Bataille R; Klein B Leukemia; 1993 Apr; 7(4):609-17. PubMed ID: 7681918 [TBL] [Abstract][Full Text] [Related]
8. Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells. Kozbor D; Moretta A; Messner HA; Moretta L; Croce CM J Immunol; 1987 Jun; 138(12):4128-32. PubMed ID: 3035021 [TBL] [Abstract][Full Text] [Related]
9. Expression of adhesion molecules LFA-3 and N-CAM on normal and malignant human plasma cells. Barker HF; Hamilton MS; Ball J; Drew M; Franklin IM Br J Haematol; 1992 Jul; 81(3):331-5. PubMed ID: 1382543 [TBL] [Abstract][Full Text] [Related]
10. Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agents. Muccio VE; Saraci E; Gilestro M; Gattei V; Zucchetto A; Astolfi M; Ruggeri M; Marzanati E; Passera R; Palumbo A; Boccadoro M; Omedè P Cytometry B Clin Cytom; 2016 Jan; 90(1):81-90. PubMed ID: 26287276 [TBL] [Abstract][Full Text] [Related]
11. Surface antigen expression of human neoplastic plasma cells includes molecules associated with lymphocyte recirculation and adhesion. Hamilton MS; Ball J; Bromidge E; Franklin IM Br J Haematol; 1991 May; 78(1):60-5. PubMed ID: 2043483 [TBL] [Abstract][Full Text] [Related]
12. Response patterns of purified myeloma cells to hematopoietic growth factors. Anderson KC; Jones RM; Morimoto C; Leavitt P; Barut BA Blood; 1989 May; 73(7):1915-24. PubMed ID: 2713508 [TBL] [Abstract][Full Text] [Related]
13. The ability of synoviocytes to support terminal differentiation of activated B cells may explain plasma cell accumulation in rheumatoid synovium. Dechanet J; Merville P; Durand I; Banchereau J; Miossec P J Clin Invest; 1995 Feb; 95(2):456-63. PubMed ID: 7532184 [TBL] [Abstract][Full Text] [Related]
14. Leu-1+ (CD5+) B cells. A major lymphoid subpopulation in human fetal spleen: phenotypic and functional studies. Antin JH; Emerson SG; Martin P; Gadol N; Ault KA J Immunol; 1986 Jan; 136(2):505-10. PubMed ID: 2934473 [TBL] [Abstract][Full Text] [Related]
15. Tumor cell heterogeneity in multiple myeloma: antigenic, morphologic, and functional studies of cells from blood and bone marrow. King MA; Nelson DS Blood; 1989 May; 73(7):1925-35. PubMed ID: 2785420 [TBL] [Abstract][Full Text] [Related]
16. CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line. Westendorf JJ; Ahmann GJ; Armitage RJ; Spriggs MK; Lust JA; Greipp PR; Katzmann JA; Jelinek DF J Immunol; 1994 Jan; 152(1):117-28. PubMed ID: 7504707 [TBL] [Abstract][Full Text] [Related]
17. A novel membrane antigen selectively expressed on terminally differentiated human B cells. Goto T; Kennel SJ; Abe M; Takishita M; Kosaka M; Solomon A; Saito S Blood; 1994 Sep; 84(6):1922-30. PubMed ID: 8080996 [TBL] [Abstract][Full Text] [Related]
18. Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation. Kubagawa H; Vogler LB; Capra JD; Conrad ME; Lawton AR; Cooper MD J Exp Med; 1979 Oct; 150(4):792-807. PubMed ID: 92518 [TBL] [Abstract][Full Text] [Related]
19. The blood B-cells and bone marrow plasma cells in patients with multiple myeloma share identical IgH rearrangements. Bergsagel PL; Masellis Smith A; Belch AR; Pilarski LM Curr Top Microbiol Immunol; 1995; 194():17-24. PubMed ID: 7534667 [TBL] [Abstract][Full Text] [Related]
20. Phenotypical and functional characterization of the idiotype-positive blood B cells in multiple myeloma. Bloem AC; Chand MA; van Camp B; Bast EJ; Ballieux RE Scand J Immunol; 1988 Dec; 28(6):791-9. PubMed ID: 2906758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]